These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21787158)
41. The relationship between the antioxidant system, oxidative stress and dialysis-related amyloidosis in hemodialysis patients. Celik G; Capraz I; Yontem M; Bilge M; Unaldi M; Mehmetoglu I Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1157-64. PubMed ID: 24231477 [TBL] [Abstract][Full Text] [Related]
42. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352 [TBL] [Abstract][Full Text] [Related]
43. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress]. Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616 [TBL] [Abstract][Full Text] [Related]
44. Free radicals and oxidative stress challenge dialysis patients: effects of two different membranes. Biasioli S; Schiavon R; Petrosino L; Cavallini L; Zambello A; De Fanti E; Giavarina D ASAIO J; 1997; 43(5):M766-72. PubMed ID: 9360150 [TBL] [Abstract][Full Text] [Related]
45. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Mimic-Oka J; Simic T; Ekmescic V; Dragicevic P Clin Nephrol; 1995 Jul; 44(1):44-8. PubMed ID: 7554532 [TBL] [Abstract][Full Text] [Related]
46. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752 [TBL] [Abstract][Full Text] [Related]
47. Dementia and depression in end stage renal disease: comparison between hemodialysis and continuous ambulatory peritoneal dialysis. Sithinamsuwan P; Niyasom S; Nidhinandana S; Supasyndh O J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S141-7. PubMed ID: 16858952 [TBL] [Abstract][Full Text] [Related]
48. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Badjatia N; Satyam A; Singh P; Seth A; Sharma A Urol Oncol; 2010; 28(4):360-7. PubMed ID: 19171490 [TBL] [Abstract][Full Text] [Related]
49. Oxidative stress in haemodialysis. Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542 [TBL] [Abstract][Full Text] [Related]
50. Nutritional status of zinc and activity superoxide dismutase in chronic renal patients undergoing hemodialysis. Noleto Magalhães RC; Guedes Borges de Araujo C; Batista de Sousa Lima V; Machado Moita Neto J; do Nascimento Nogueira N; do Nascimento Marreiro D Nutr Hosp; 2011; 26(6):1456-61. PubMed ID: 22411396 [TBL] [Abstract][Full Text] [Related]
52. Effects of the Mediterranean diet supplemented with coenzyme q10 on metabolomic profiles in elderly men and women. González-Guardia L; Yubero-Serrano EM; Delgado-Lista J; Perez-Martinez P; Garcia-Rios A; Marin C; Camargo A; Delgado-Casado N; Roche HM; Perez-Jimenez F; Brennan L; López-Miranda J J Gerontol A Biol Sci Med Sci; 2015 Jan; 70(1):78-84. PubMed ID: 24986061 [TBL] [Abstract][Full Text] [Related]
53. The alteration in Cu/Zn superoxide dismutase and adhesion molecules concentrations in diabetic patients with chronic kidney disease: the effect of dialysis treatment. Pawlak K; Mysliwiec M; Pawlak D Diabetes Res Clin Pract; 2012 Nov; 98(2):264-70. PubMed ID: 23020933 [TBL] [Abstract][Full Text] [Related]
55. Oxidant-antioxidant status in acute and chronic renal failure. Ghoreshi Z; Jagtap PE; Ahaley SK; Gandhi R Indian J Med Sci; 2000 Apr; 54(4):131-5. PubMed ID: 11227121 [TBL] [Abstract][Full Text] [Related]
56. Hypoalbuminemia and oxidative stress in patients on renal hemodialysis program. de Castro LL; de Carvalho e Martins Mdo C; Garcez AM; Pacheco JF; Cunha FV; Moita Neto JM; de Freitas MC; de Melo Cunha LA Nutr Hosp; 2014 Oct; 30(4):952-9. PubMed ID: 25335687 [TBL] [Abstract][Full Text] [Related]
57. [A study of oxidative stress markers and antioxidant system activity in the serum of hemodialysis patients]. Lukoseviciene R; Ziaukiene G; Urbeliene J; Kalpokaite Z; Glemziene I Medicina (Kaunas); 2003; 39 Suppl 1():115-8. PubMed ID: 12761432 [TBL] [Abstract][Full Text] [Related]
58. [Malondialdehyde and selected antioxidant plasma levels in conservatively treated patients with kidney diseases]. Gazdikova K; Gvozdjakova A; Kucharska J; Spustova V; Braunova Z; Dzurik R Bratisl Lek Listy; 2000; 101(9):490-4. PubMed ID: 11187051 [TBL] [Abstract][Full Text] [Related]
59. The effect of superoxide dismutase supplementation on TNF-α and TGF-β levels in patients undergoing hemodialysis. Supriyadi R; Rakhmawati Kurniaatmaja E; Huang I; Sukesi L; Makmun A Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):893-898. PubMed ID: 36808335 [TBL] [Abstract][Full Text] [Related]
60. Effects of silymarin on biochemical and oxidative stress markers in end-stage renal disease patients undergoing peritoneal dialysis. Firuzi O; Khajehrezaei S; Ezzatzadegan S; Nejati M; Jahanshahi KA; Roozbeh J Hemodial Int; 2016 Oct; 20(4):558-563. PubMed ID: 27040041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]